Neuroscience
With New Sleeping Pill, New Acceptability?
By ANDREW POLLACK
The New York Times
17 December 2004
Is it a wake-up call for the sleeping pill market? With Wednesday's approval of Sepracor's new drug, Lunesta, a taboo in the use of sleeping pills has been broken. Lunesta is the first sleeping pill whose label will not recommend it be taken for only 7 to 10 days.
[ ... Read the full article ... ] (free registration required)
- Elsewhere
For when you've had enough of reading journal articles: The sleeping pill that is awakening coma patients. The lady who changed her husband's behaviour using animal training techniques (free registration required). Does neuroscience hold the...
- Cognitive Pharmacological Enhancement
From The Observer: Can a daily pill really boost your brain power? In America, university students are taking illegally obtained prescription drugs to make them more intelligent. But would you pop a smart pill to improve your performance? Margaret Talbot...
- Business World: New Insomnia Meds, Including Takeda's Ramelteon (rozerem, Tak-375)
A brief overview to some of the anticipated insomnia medications trending from this year to next, this is from a recent Reuters report, as published on the International Herald Tribune website:New entries shake insomnia market's slumber Reuters ...
- Business World: Takeda's Ramelteon (tak-375)
A Reuters report:Takeda may extend sleeping pill's use for Alzheimer's Mon Jul 11, 2005 05:41 AM ET TOKYO, July 11 (Reuters) - Japan's biggest drug maker, Takeda Pharmaceutical Co. Ltd ... said on Monday it is on track to release a sleeping...
- Tysabri (natalizumab): An Additional Case
Rare Infection Is Confirmed in 2nd Patient on M.S. Drug By ANDREW POLLACK The New York Times Published: March 4, 2005 The makers of the multiple sclerosis drug Tysabri said yesterday that a second patient who used the drug had been confirmed to be suffering...
Neuroscience
Lunesta (Eszopiclone)
With New Sleeping Pill, New Acceptability?
By ANDREW POLLACK
The New York Times
17 December 2004
Is it a wake-up call for the sleeping pill market? With Wednesday's approval of Sepracor's new drug, Lunesta, a taboo in the use of sleeping pills has been broken. Lunesta is the first sleeping pill whose label will not recommend it be taken for only 7 to 10 days.
[ ... Read the full article ... ] (free registration required)
- Elsewhere
For when you've had enough of reading journal articles: The sleeping pill that is awakening coma patients. The lady who changed her husband's behaviour using animal training techniques (free registration required). Does neuroscience hold the...
- Cognitive Pharmacological Enhancement
From The Observer: Can a daily pill really boost your brain power? In America, university students are taking illegally obtained prescription drugs to make them more intelligent. But would you pop a smart pill to improve your performance? Margaret Talbot...
- Business World: New Insomnia Meds, Including Takeda's Ramelteon (rozerem, Tak-375)
A brief overview to some of the anticipated insomnia medications trending from this year to next, this is from a recent Reuters report, as published on the International Herald Tribune website:New entries shake insomnia market's slumber Reuters ...
- Business World: Takeda's Ramelteon (tak-375)
A Reuters report:Takeda may extend sleeping pill's use for Alzheimer's Mon Jul 11, 2005 05:41 AM ET TOKYO, July 11 (Reuters) - Japan's biggest drug maker, Takeda Pharmaceutical Co. Ltd ... said on Monday it is on track to release a sleeping...
- Tysabri (natalizumab): An Additional Case
Rare Infection Is Confirmed in 2nd Patient on M.S. Drug By ANDREW POLLACK The New York Times Published: March 4, 2005 The makers of the multiple sclerosis drug Tysabri said yesterday that a second patient who used the drug had been confirmed to be suffering...